Inhibition of experimental autoimmune vitiligo by oral administration of mushroom tyrosinase

Cytobios

Volumn 2001, Issue 408, 2001, Pages 27-34

  Zehtab, T ^a   Yazdanparast, R ^b   Rafieii, S ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Experimental autoimmune vitiligo; Human vitiligo; Mushroom tyrosinase; Oral tolerance

Indexed keywords

MONOPHENOL MONOOXYGENASE;

AGARICUS; ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; C57BL MOUSE; DELAYED HYPERSENSITIVITY; DISEASE MODEL; ENZYMOLOGY; FEMALE; IMMUNOLOGY; METABOLISM; MOUSE; ORAL DRUG ADMINISTRATION; PATHOLOGY; SKIN; VITILIGO;

ADMINISTRATION, ORAL; AGARICUS; ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; FEMALE; HYPERSENSITIVITY, DELAYED; MICE; MICE, INBRED C57BL; MONOPHENOL MONOOXYGENASE; SKIN; VITILIGO;

EID: 0035228978     PISSN: 00114529     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. BAHARAV E., Merimski O., Shoenfeld Y., Zigelman R., Gilbrud B., Yecheskel G., Youinous P. and Fishman P. 1996. Tyrosinase as an autoantigen in patients with vitiligo. Clin. exp. Immunol. 105 84-8.
2. BITAR D. M. and Whitacre C. C. 1988. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. Cell. Immunol. 112 364-70.
3. BROSTOFF J., Bor S. and Feiwel M. 1996. Autoantibodies in patients with vitiligo. Lancet 26 177-8.
4. HANN S. K., Chen D. and Bystryn J-C. 1997. Systemic steroids suppress antimelanocyte antibodies in vitiligo. J. Cutaneous Med. Surg. 1 193-5.
5. HERBRINK P., Van Bussel F. I. and Warnaar S. O. 1982. The antigen spot test (AST): a highly sensitive assay for the detection of antibodies. J. Immunol. Meth. 48 293-8.
6. HERTZ K. C., Gazze L. A., Kirkpatrick C. H. and Katz S. I. 1997. Autoimmune vitiligo: detection of antibodies to melanin producing cells. N. Engl. J. Med. 22 634-7.
7. HIBI T. and Saito Y. 1985. A dot immunobinding assay for the detection of tobacco mosiac virus in infected tissues. J. gen. Virol. 66 1191-4.
8. HOROWITZ N. H., Fling M. and Horn G. 1971. Tyrosinase (Neurospora crassa). Meth. Enzymol. 17 615-6.
9. JOHNSTONE A. and Thorre R. 1990. (Editors), Immunochemistry in practice. Second editn. pp 30-2. Blackwell Scientific Publications.
10. LE POOLE C. I., Van den Wijngaard R. M. J. G. J., Westerhof W. and Das P. K. 1996. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am. J. Path. 148 1219-28.
11. + T lymphocytes. J. Immunol. 142 748-52.
12. MANDRY R. C., Ortiz L. J., Lugo-Somolinos A. and Sanchez J. L. 1996. Organ specific autoantibodies in vitiligo patients and their relatives. Int. J. Dermatol. 35 18-21.
13. NAUGHTON G. K., Eisinger M. and Bystryn J. C. 1983. Antibodies to normal human melanocytes in vitiligo. J. exp. Med. 158 246-51.
14. NELSON R. M. and Mason H. S. 1971. Tyrosinase (mushroom). Meth. Enzymol. 17 626-32.
15. NUSSENNBLATT R. B., Caspi R. R., Mahdi R., Chan C. C., Roberge F., Lider O. and Weiner H. L. 1990. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol. 144 1689-95.
16. OGG G., Rod Dunbar P., Romero P., Chen J. and Cerundolo V. 1998. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J. exp. Med. 188 1203-8.
17. PALKOWSKI M. R., Nordlund M. L., Rheins L. A. and Nordlund J. J. 1987. Langerhans' cells in hair follicles of depigmentation C57BL/ler.vit.vit mouse. Arch. Dermatol. 123 1022-8.
18. PARK Y. K., Kim N. S., Hann S. K. and Im S. 1996. Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients. J. Dermatol. Sci. 11 111-20.
19. 65). Clin. Immunol. Immunopathol. 76 90-5.
20. SONG Y. H., Connor E., Li Y., Zorovich B., Balducci P. and Maclaren N. 1994. The role of tyrosinase in autoimmune vitiligo. Lancet 344 1049-52.
21. SONG Y. H., Li Y. and Maclaren N. 1996. The nature of autoantibodies targeted in autoimmune endocrine disease. Immunol. Today 17 232-8.
22. STROBEL S. and Ferguson A. 1987. Persistence of oral tolerance in mice fed ovalbumin is different for humoral and cell-mediated immune responses. Immunol. 60 317-8.
23. WALKER J. M. 1996. Nondenaturing polyacrylamide gel electrophoresis of proteins. In The Protein Protocols Handbook. pp 51-4. Edited by J M. Walker. Humana Press Inc., Totowa, New Jersey, U.S.A.
24. YAGI H., Tokura Y., Furukawa F. and Takigawa M. 1997. Vitiligo with raised inflammatory borders: involvement of T cell immunity and keratinocytes expressing MHC class II and ICAM-1 molecules. Eur. J. Dermatol. 7 19-22.
25. YOSHIDA T., Hachimura S. and Kaminogava S. 1997. The oral administration of low dose antigen induces activation followed by tolerization, while high dose antigen induces tolerance without activation. Clin. Immunol. Immunopathol. 82 207-15.
26. YU H-S., Chang K-L., Yu C-L., Li H-F., Wu M-T. and Wu C-S. 1997. Alternations in IL-6, IL-8, GM-CSF, TNF-α and IFN-α release by peripheral mononuclear cells in patients with active vitiligo. J. Invest. Dermatol. 108 527-9.
27. ZHANG Z. J., Lee C. S. Y., Lider O. and Weiner H. L. 1990. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J. Immunol. 145 2489-93.